These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1925813)

  • 1. Perindopril and reference antihypertensives.
    Thurston H
    S Afr Med J; 1991 Oct; Suppl():10-4; discussion 15. PubMed ID: 1925813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of the efficacy and tolerance of perindopril, a new converting enzyme inhibitor and of atenolol, a beta blocker].
    Rorive G; Creytens G; Ruhwiedel M; Van de Voorde K
    Rev Med Liege; 1990 Feb; 45(2):62-8. PubMed ID: 2180020
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
    Thurston H; Desche P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S45-9. PubMed ID: 1725202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study PROTECT (Perindopril Regression of Vascular Thickening). European Community Trial].
    Tarentini Trojani F
    Clin Ter; 1994 Nov; 145(11):411-2. PubMed ID: 7889727
    [No Abstract]   [Full Text] [Related]  

  • 7. [Suppression of angiotensin-converting enzyme and myocardial ischemia].
    Eliseev OM
    Ter Arkh; 1999; 71(3):73-6. PubMed ID: 10234773
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
    Bönner G; Lederle RM; Scholze J; Stumpe KO
    Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension.
    Thybo NK; Stephens N; Cooper A; Aalkjaer C; Heagerty AM; Mulvany MJ
    Hypertension; 1995 Apr; 25(4 Pt 1):474-81. PubMed ID: 7721386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of perindopril in hypertension.
    Morgan T; Anderson A
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():61-5. PubMed ID: 1395118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
    Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
    Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perindopril: first-line treatment for hypertension.
    Zanchetti A; Desche P
    Clin Exp Hypertens A; 1989; 11 Suppl 2():555-73. PubMed ID: 2691129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the dose-effect relationship of perindopril in the treatment of hypertension.
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Clin Exp Hypertens A; 1989; 11 Suppl 2():521-34. PubMed ID: 2605801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis.
    Gasowski J; Wilkins A; Drzewoski J; Kłoś J; Gaciong Z; Kabat M; Grodzicki T
    Cardiol J; 2010; 17(3):259-66. PubMed ID: 20535716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of perindopril (prestarium) in arterial hypertension].
    Filatova NP
    Ter Arkh; 1995; 67(9):81-3. PubMed ID: 7495054
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of perindopril on structural and functional changes in hypertensive arteries.
    Thomas JR; Asmar RG; Safar ME
    S Afr Med J; 1991 Oct; Suppl():6-9. PubMed ID: 1925815
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM; Schaefer A
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
    Widimský J; Fedelesová V; Uhlír O
    Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.